CMF
Device Osteogenesis Stimulators
PDI 00888912011495
General payments
$188,973
Research payments
$235,515
Through program year 2025, $188,973 in general payments and $235,515 in research payments were reported against CMF (Osteogenesis Stimulators).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $51,429 | 851 |
| 2024 | General | $84,974 | 714 |
| 2024 | Research | $36,735 | 5 |
| 2023 | General | $45,833 | 506 |
| 2023 | Research | $191,240 | 41 |
| 2022 | General | $5,146 | 234 |
| 2022 | Research | $7,540 | 4 |
| 2021 | General | $1,590 | 45 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 37 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 38 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,350 general · 50 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.